# XO1

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xo1

- Industry: Pharmaceuticals
- Headquarters: UK
- Website: www.xo1.co.uk
- Total disclosed funding: $11M
- Latest round: Series A (Jun 17, 2013)
- Investors on record: 1

## About

XO1 Ltd. develops innovative solutions designed to enhance operational efficiency across various sectors, addressing critical challenges faced by clients in high-performance industries.Founded in 2013 in the UK, XO1 Ltd. specializes in creating solutions tailored for industries that prioritize high performance and reliability. Mohammad Abdulaal, the founder, has a history of entrepreneurial endeavors, although specific details about previous companies are not available. The company has engaged in 2 funding rounds, with the latest being a Series A round raising USD 11.00 mn on March 19, 2015, primarily from Index Ventures. This funding has contributed to the total amount raised of USD 11.00 mn.XO1 Ltd. offers a range of innovative products aimed at improving efficiency and effectiveness for clients in technology, healthcare, and manufacturing sectors. These products are designed to resolve operational bottlenecks and enhance scalability, serving a wide client base primarily in North America, Europe, and select Asia-Pacific regions. The company’s offerings have gained traction for their ability to deliver measurable value to users seeking to optimize their operations.In the most recent year of 2022, XO1 Ltd. reported zero revenue and zero EBITDA, indicating no financial transactions or income during that period.Following its acquisition by Janssen Pharmaceuticals in March 2015, XO1 is strategizing future growth by developing new products aimed at enhancing operational capabilities. The company plans to expand into new markets, targeting specific regions in Asia-Pacific, with potential launches expected in the next couple of years. The funding acquired during the Series A round is intended to support these initiatives, allowing for substantial investment in product development and market penetration.

## Funding rounds

- Series A, Jun 17, 2013, $11M — Index Ventures

## Investors

- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Series A